Edit
MBio Diagnostics
http://www.mbiodx.com/Last activity: 18.02.2020
Active - Reference to LightDeckDx
MBio Diagnostics will be the platform of choice for on-the-spot testing across industries and applications. When we think of on-the-spot testing, we often think of home pregnancy tests—quick and convenient, but can leave you guessing when the results are faint. That uncertainty defines the limitations of today’s technology, based on paper strips with minimal controls and an inherent ambiguity that is not fixed even with an “electronic eye” readout. The desired solution is a system that provides precise quantitative readout, while preserving the simplicity and speed of the “home pregnancy”-type test.
Employees: 51-200
Total raised: $15.5M
Founded date: 2009
Investors 2
| Date | Name | Website |
| - | Technology... | pivotcente... |
| - | Capital fo... | capitalfor... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.08.2018 | Series B | $6M | - |
| 22.05.2015 | Series B | $6.3M | - |
| 26.09.2012 | - | $3.2M | - |
Mentions in press and media 9
| Date | Title | Description |
| 18.02.2020 | Boulder firm tapped for work on detection of radiation, anthrax | The ability to detect both radiation exposure and anthrax infections could be enhanced through work being undertaken by a Boulder clinical diagnostics and testing company which has landed contracts with important implications for homeland s... |
| 21.08.2018 | MBio Diagnostics Raises Additional $6M in Series B Financing | MBio Diagnostics, Inc., a Boulder, CO-based developer of rapid, on-the-spot clinical diagnostics and sample testing solutions, raised an additional $6m in Series B financing. The round was led by new and existing investors, including MBio’s... |
| 22.05.2015 | Colorado startup MBio Diagnostics raises a $6.3M Series B | Working with the Switzerland-based Foundation for Innovative New Diagnostics, mBio said it developed a disposable cartridge that can profile tuberculosis proteins. It was tested in Peru and Vietnam over an 18-month period – and MBio said th... |
| 22.05.2015 | MBio Diagnostics Closes $6.3M Series B Funding | MBio Diagnostics Inc., a Boulder, CO-based provider of clinical diagnostics and sample testing, closed a $6.3m Series B funding. The round was led by unnamed new and existing investors. The company intends to use the funds for the refinemen... |
| 20.01.2014 | Mhealth company’s disruptive diagnostics platform on track for launch in H2 2014 | When will the U.S. market be ready for disruptive mobile health diagnostics tools? That’s a question at the front of the mind of mBio Diagnostics CEO Christopher Myatt. The company is gearing up for the commercial launch in sub-Saharan Afri... |
| 26.09.2012 | mBio Diagnostics gets $3.2M to bring bedside testing for infectious diseases to developing countries | Those first products include a CD4 T-cell enumeration test, which is useful in assessing the immune system of patients with HIV infections, and a device that would screen pregnant women for HIV and syphilis. According to Myatt, one thing th... |
| - | mBio Diagnostics gets $3.2M to bring bedside testing for infectious diseases to developing countries | A portable, easy-to-use bedside device could make it easier for clinics in developing countries to test for HIV, hepatitis, syphilis and other infectious diseases. mBio Diagnostics Inc. just brought in $3.9 million to begin commercializing ... |
| - | Mhealth company’s disruptive diagnostics platform on track for launch in H2 2014 | When will the U.S. market be ready for disruptive mobile health diagnostics tools? That’s a question at the front of the mind of mBio Diagnostics CEO Christopher Myatt. The company is gearing up for the commercial launch in sub-Saharan Afri... |
| - | Colorado startup MBio Diagnostics raises a $6.3M Series B | Colorado startup MBio Diagnostics just closed a $6.3 million Series B round. The company says it offers fast, on-the-spot clinical diagnostics – as well as sample testing for the food safety industry. A spokeswoman said MBio isn’t disclosin... |